Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B
2017
Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
11
Citations
NaN
KQI